Autologous Cell Therapy After Stroke

Withdrawn

Phase 1 Results N/A

Summary of Purpose

This study will examine the safety of two different cellular therapies in the treatment of stroke. Trial Stopped: Not funded

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 February 2016.

1 Jan 2016 26 May 2009 1 Dec 2017 1 Dec 2017 1 Feb 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment

Contacts